TMOTHERMO FISHER SCIENTIFIC INC.

NYSE thermofisher.com


$ 594.39 $ 19.77 (3.44 %)    

Thursday, 25-Jul-2024 15:59:57 EDT
QQQ $ 458.17 $ -5.11 (-1.1 %)
DIA $ 399.49 $ 0.82 (0.21 %)
SPY $ 538.20 $ -2.82 (-0.52 %)
TLT $ 92.27 $ 0.75 (0.82 %)
GLD $ 218.35 $ -3.47 (-1.56 %)
$ 594.5
$ 576.30
-- x --
-- x --
$ 573.69 - $ 603.80
$ 414.76 - $ 603.82
3,579,108
na
228.29B
$ 0.80
$ 37.83
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-30-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 07-01-2023 10-Q
5 05-05-2023 04-01-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-04-2022 10-01-2022 10-Q
8 08-05-2022 07-02-2022 10-Q
9 05-06-2022 04-02-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 10-02-2021 10-Q
12 08-06-2021 07-03-2021 10-Q
13 05-07-2021 04-03-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-30-2020 09-26-2020 10-Q
16 07-31-2020 06-27-2020 10-Q
17 05-01-2020 03-28-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-01-2019 09-28-2019 10-Q
20 08-02-2019 06-29-2019 10-Q
21 05-03-2019 03-30-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-02-2018 09-29-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-28-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 07-01-2017 10-Q
29 05-05-2017 04-01-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-04-2016 10-01-2016 10-Q
32 08-05-2016 07-02-2016 10-Q
33 05-06-2016 04-02-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 10-30-2015 09-26-2015 10-Q
36 07-31-2015 06-27-2015 10-Q
37 05-01-2015 03-28-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 10-31-2014 09-27-2014 10-Q
40 08-01-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-thermo-fisher-scientific-raises-price-target-to-658

TD Cowen analyst Dan Brennan maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $648 ...

 raymond-james-maintains-outperform-on-thermo-fisher-scientific-raises-price-target-to-660

Raymond James analyst Andrew Cooper maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price tar...

 rbc-capital-maintains-outperform-on-thermo-fisher-scientific-raises-price-target-to-664

RBC Capital analyst Conor McNamara maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price targ...

 stifel-maintains-buy-on-thermo-fisher-scientific-raises-price-target-to-615

Stifel analyst Daniel Arias maintains Thermo Fisher Scientific (NYSE:TMO) with a Buy and raises the price target from $600 t...

 baird-maintains-outperform-on-thermo-fisher-scientific-raises-price-target-to-632

Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and raises the price target ...

 us-stocks-tumble-magnificent-7-wipe-out-570-billion-as-mega-tech-earnings-disappoint-vix-spikes-whats-driving-markets-wednesday

Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in ov...

 thermo-fisher-q2-earnings-marginal-revenue-dip-completes-olink-acquisition-lifts-annual-profit-outlook

Thermo Fisher Scientific's Q2 revenue of $10.54 billion surpassed expectations, with segments showing mixed results. Adjust...

 us-stocks-could-open-sharply-lower-as-tesla-alphabet-earnings-offer-no-cheer-analyst-says-this-bodes-well-for-small-caps-only-takes-a-small-spark-to-ignite-a-powerful-move

Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Al...

 thermo-fisher-scientific-q2-2024-adj-eps-537-beats-512-estimate-sales-10540b-beat-10511b-estimate

Thermo Fisher Scientific (NYSE:TMO) reported quarterly earnings of $5.37 per share which beat the analyst consensus estimate of...

 tesla-alphabet-gm-ford-lead-earnings-parade-this-week-as-market-struggles-to-sustain-the-summer-rally

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Core News & Articles

New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to ...

 stock-of-the-day-how-to-predict-thermo-fisher-scientific-trend-reversals

Stocks have a tendency to reverse and move in the opposite direction after they rally to resistance or drop to support.